Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03907735 · ClinicalTrials.gov registry record
Oxytocin Receptor Expression in Pregnancy
A clinical trial of Post-Abortion and Hemorrhage, Obstetric, sponsored by Oregon Health and Science University.
- Active
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT03907735 is a study of Post-Abortion and Hemorrhage, Obstetric that is active but no longer recruiting, run by Oregon Health and Science University. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03907735, a study of Post-Abortion and Hemorrhage, Obstetric, is active but no longer recruiting, sponsored by Oregon Health and Science University.
- ACTIVE NOT RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to determine when during gestation oxytocin receptor (OXTR) expression increases in the myometrium, which will contribute new insight to the management of obstetric hemorrhage and our understanding of normal and abnormal labor.
Conditions Studied
Interventions
- OTHER Myometrial tissue sample collection
Study Locations (1)
Oregon
- Oregon Health & Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2019-06-03 |
| Est. Completion | 2025-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03907735
The ClinicalTrials.gov registry entry for NCT03907735 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Post-Abortion appearing as the primary indexed condition, and to 1 intervention - of which Myometrial tissue sample collection is the first listed.
NCT03907735 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT03907735 about?
NCT03907735 is a clinical study titled "Oxytocin Receptor Expression in Pregnancy". This study aims to determine when during gestation oxytocin receptor (OXTR) expression increases in the myometrium, which will contribute new insight to the management of obstetric hemorrhage and our understanding of normal and abnormal labor.
What is the current status of trial NCT03907735?
This trial is currently active not recruiting. The enrollment target is 30 participants. The study started on 2019-06-03. Estimated completion is 2025-08.
What conditions does trial NCT03907735 study?
This clinical trial studies the following conditions: Post-Abortion, Hemorrhage, Obstetric.
What interventions are being tested in trial NCT03907735?
The interventions under investigation include: Myometrial tissue sample collection (OTHER).
Who is sponsoring clinical trial NCT03907735?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03907735 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.